Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting beta-catenin C-terminal domain/S1PR1 axis for vascular remodeling

April 19, 2022

Bridge Biotherapeutics inlicenses Shaperon's IPF candidate BBT-209

April 19, 2022

Biocytogen and CtM Biotech to develop novel immunotherapy candidates

April 19, 2022

Microbe-sensing mechanism via neuronal Nod2 regulates appetite and metabolism

April 19, 2022

Cellectis details activity of allogeneic CAR-T cells targeting CD20 and CD22: UCART20x22

April 19, 2022

Shanghai Meiyue Biotech Development patents pantetheinase inhibitors

April 19, 2022

New MAP4K1 inhibitors identified at Shenzhen Ionova Life Science

April 19, 2022

Medshine Discovery presents new PTPN11 inhibitors

April 19, 2022

New Bruton tyrosine kinase inhibitors synthesized at GenFleet Therapeutics

April 19, 2022

Shanghai Ringene Biopharma discovers S-adenosylmethionine synthase isoform type-2 inhibitors

April 19, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...